Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

131 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Phase 0 clinical chemoprevention trial of the Akt inhibitor SR13668.
Reid JM, Walden CA, Qin R, Ziegler KL, Haslam JL, Rajewski RA, Warndahl R, Fitting CL, Boring D, Szabo E, Crowell J, Perloff M, Jong L, Bauer BA, Mandrekar SJ, Ames MM, Limburg PJ; Cancer Prevention Network. Reid JM, et al. Among authors: perloff m. Cancer Prev Res (Phila). 2011 Mar;4(3):347-53. doi: 10.1158/1940-6207.CAPR-10-0313. Cancer Prev Res (Phila). 2011. PMID: 21372034 Free PMC article. Clinical Trial.
Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent.
Boocock DJ, Faust GE, Patel KR, Schinas AM, Brown VA, Ducharme MP, Booth TD, Crowell JA, Perloff M, Gescher AJ, Steward WP, Brenner DE. Boocock DJ, et al. Among authors: perloff m. Cancer Epidemiol Biomarkers Prev. 2007 Jun;16(6):1246-52. doi: 10.1158/1055-9965.EPI-07-0022. Cancer Epidemiol Biomarkers Prev. 2007. PMID: 17548692 Clinical Trial.
Methyl selenocysteine: single-dose pharmacokinetics in men.
Marshall JR, Ip C, Romano K, Fetterly G, Fakih M, Jovanovic B, Perloff M, Crowell J, Davis W, French-Christy R, Dew A, Coomes M, Bergan R. Marshall JR, et al. Among authors: perloff m. Cancer Prev Res (Phila). 2011 Nov;4(11):1938-44. doi: 10.1158/1940-6207.CAPR-10-0259. Epub 2011 Aug 16. Cancer Prev Res (Phila). 2011. PMID: 21846796 Free PMC article. Clinical Trial.
Bowman birk inhibitor concentrate and oral leukoplakia: a randomized phase IIb trial.
Armstrong WB, Taylor TH, Kennedy AR, Melrose RJ, Messadi DV, Gu M, Le AD, Perloff M, Civantos F, Goodwin WJ, Wirth LJ, Kerr AR, Meyskens FL Jr. Armstrong WB, et al. Among authors: perloff m. Cancer Prev Res (Phila). 2013 May;6(5):410-8. doi: 10.1158/1940-6207.CAPR-13-0004. Cancer Prev Res (Phila). 2013. PMID: 23639862 Free PMC article. Clinical Trial.
Repeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: safety, pharmacokinetics, and effect on the insulin-like growth factor axis.
Brown VA, Patel KR, Viskaduraki M, Crowell JA, Perloff M, Booth TD, Vasilinin G, Sen A, Schinas AM, Piccirilli G, Brown K, Steward WP, Gescher AJ, Brenner DE. Brown VA, et al. Among authors: perloff m. Cancer Res. 2010 Nov 15;70(22):9003-11. doi: 10.1158/0008-5472.CAN-10-2364. Epub 2010 Oct 8. Cancer Res. 2010. PMID: 20935227 Free PMC article. Clinical Trial.
Fenretinide: a prototype cancer prevention drug.
Malone W, Perloff M, Crowell J, Sigman C, Higley H. Malone W, et al. Among authors: perloff m. Expert Opin Investig Drugs. 2003 Nov;12(11):1829-42. doi: 10.1517/13543784.12.11.1829. Expert Opin Investig Drugs. 2003. PMID: 14585058 Review.
Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients.
Patel KR, Brown VA, Jones DJ, Britton RG, Hemingway D, Miller AS, West KP, Booth TD, Perloff M, Crowell JA, Brenner DE, Steward WP, Gescher AJ, Brown K. Patel KR, et al. Among authors: perloff m. Cancer Res. 2010 Oct 1;70(19):7392-9. doi: 10.1158/0008-5472.CAN-10-2027. Epub 2010 Sep 14. Cancer Res. 2010. PMID: 20841478 Free PMC article. Clinical Trial.
131 results